Coonbio locates in Xiaoshan Economical Development Zone of Zhejiang Province , China, the main technical of the corporation is bio-engineering, specializing in development and research on genetic engineering technology and working on the industrialization of biological pharmacy. It is a high-tech enterprise that combines R&D, manufacture, marketing and sales.
Coonbio is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in health, beauty, .we offer novel therapies on a platform of affordable innovation.
Coonbio is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. From discovery to development and commercialisation, we have the defining science, cost-effective drug development capabilities and significant manufacturing capacity to move ideas to market.
Leveraging China's globally competitive cost base and exceptional scientific people resource, we are advancing our in-house R&D programs, while also providing custom and clinical research services to international pharmaceutical.
Coonbio have in a wide range cooperation of biological technology areas with USA, UK and Japan.also custom and manufacture some bio-engineering products:recombinant protein drugs and gene-engineered Active Pharmaceutical Ingredients(APIs), such as Recombinant human Epidermal Growth Factor(rhEGF), Recombinant human Growth hormone(rhGH), Recombinant human Insulin-like Growth Factor(rhIGF-1), and Recombinant human Keratinocye Growth Factor-2 (rhKGF-2), rhFollistatin 344 , and so on.